Concepedia

Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

Ticiana B. Leal, Scot C. Remick, Chris H. Takimoto, Ramesh K. Ramanathan, Angela M. Davies, Merrill J. Egorin, Anne Hamilton, Patricia LoRusso, Stephen Shibata, Heinz Josef Lenz,

Cancer Chemotherapy and Pharmacology · 2011 · 41 citations · 23 references

DOIFull text

Open access

Concepts

References

23

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

Amer A. Beg, David Baltimore · Science · 1996 · 3.1K citations

, , +17

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

, , +12

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

Cheson Bd, J M Bennett, Michael R. Grever et al. · Blood · 1996 · 1.8K citations

, , +12

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Teru Hideshima, Paul G. Richardson, D Chauhan et al. · PubMed · 2001 · 1.5K citations

, , +17